Literature DB >> 19190483

Voluntary activation of the knee extensors in chronic poststroke subjects.

Michael Miller1, Ulla-Britt Flansbjer, Jan Lexell.   

Abstract

OBJECTIVE: To assess the extent to which knee extensor muscle weakness in subjects with chronic mild to moderate poststroke hemiparesis is caused by a decreased voluntary activation.
DESIGN: Forty community dwelling and ambulant men and women (mean age, 59.8 +/- 5.5 yrs) with residual hemiparesis (19.2 +/- 8.5 mos poststroke) were tested. Torque measurements were performed on a computerized dynamometer and the superimposed electrical stimulation technique was used to assess voluntary activation of the knee extensors in both the paretic and the nonparetic lower limbs.
RESULTS: The mean voluntary activation ratio of the knee extensors in the nonparetic and paretic leg was 0.97 +/- 0.04 and 0.86 +/- 0.13, respectively. Subjects who had a greater relative weakness, implying a more pronounced poststroke impairment, also had lower voluntary activation ratios. The mean percentage difference in total torque between the nonparetic and the paretic knee extensors after the electrical stimulation was 36.4% +/- 17.0%.
CONCLUSIONS: Paretic knee extensor muscle weakness in chronic poststroke subjects is only partially explained by a reduced voluntary activation ability, indicating that other neuromuscular structural or functional factors contribute to poststroke hemiparetic muscle weakness.

Entities:  

Mesh:

Year:  2009        PMID: 19190483     DOI: 10.1097/PHM.0b013e318198b569

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  9 in total

1.  Alterations in peripheral muscle contractile characteristics following high and low intensity bouts of exercise.

Authors:  Martyn G Morris; Helen Dawes; Ken Howells; Oona M Scott; Mary Cramp; Hooshang Izadi
Journal:  Eur J Appl Physiol       Date:  2011-05-10       Impact factor: 3.078

2.  Ischemic conditioning increases strength and volitional activation of paretic muscle in chronic stroke: a pilot study.

Authors:  Allison S Hyngstrom; Spencer A Murphy; Jennifer Nguyen; Brian D Schmit; Francesco Negro; David D Gutterman; Matthew J Durand
Journal:  J Appl Physiol (1985)       Date:  2018-02-08

Review 3.  Skeletal muscle changes following stroke: a systematic review and comparison to healthy individuals.

Authors:  Jennifer L Hunnicutt; Chris M Gregory
Journal:  Top Stroke Rehabil       Date:  2017-03-02       Impact factor: 2.119

4.  Corticospinal tract integrity correlates with knee extensor weakness in chronic stroke survivors.

Authors:  Sangeetha Madhavan; Chandramouli Krishnan; Arun Jayaraman; William Z Rymer; James W Stinear
Journal:  Clin Neurophysiol       Date:  2011-02-17       Impact factor: 3.708

5.  Skeletal Muscle Changes in the First Three Months of Stroke Recovery: A Systematic Review.

Authors:  David Beckwée; Lotte Cuypers; Nina Lefeber; Emma De Keersmaecker; Ellen Scheys; Wout Van Hees; Stany Perkisas; Sylvie De Raedt; Eric Kerckhofs; Ivan Bautmans; Eva Swinnen
Journal:  J Rehabil Med       Date:  2022-10-04       Impact factor: 3.959

6.  Activation deficit correlates with weakness in chronic stroke: evidence from evoked and voluntary EMG recordings.

Authors:  Sheng Li; Jie Liu; Minal Bhadane; Ping Zhou; W Zev Rymer
Journal:  Clin Neurophysiol       Date:  2014-04-02       Impact factor: 3.708

7.  Central activation deficits contribute to post stroke lingual weakness in a rat model.

Authors:  Miranda J Cullins; John A Russell; Zoe E Booth; Nadine P Connor
Journal:  J Appl Physiol (1985)       Date:  2021-02-18

8.  Voluntary Activation is Reduced in Both the More- and Less-Affected Upper Limbs after Unilateral Stroke.

Authors:  Jocelyn L Bowden; Janet L Taylor; Penelope A McNulty
Journal:  Front Neurol       Date:  2014-11-19       Impact factor: 4.003

Review 9.  The Motion of Body Center of Mass During Walking: A Review Oriented to Clinical Applications.

Authors:  Luigi Tesio; Viviana Rota
Journal:  Front Neurol       Date:  2019-09-20       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.